This trial is terminated!
Search for a recruiting clinical trial for your condition
Back to search
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Steroid Refractory Acute Graft Versus Host Disease
and you are
between 1 and 21
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a single-arm, open-label, multicenter study of the efficacy of UVADEX® (methoxsalen) Sterile Solution in conjunction with THERAKOS® CELLEX® Photopheresis Systems (ECP) in pediatric participants with steroid-refractory aGvHD. The study is composed of Screening, Treatment, and Follow-up Periods.

Provided treatments

  • Drug: Methoxsalen
  • Procedure: Extracorporeal Photopheresis (ECP)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Results
Tris trial is registered with FDA with number: NCT02524847. The sponsor of the trial is Therakos, Inc., a Mallinckrodt Company and it is looking for 29 volunteers for the current phase.
Official trial title:
Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)